Status:
COMPLETED
Awareness, Care & Treatment In Obesity Management - An Observation in Asia Pacific
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Obesity
Eligibility:
All Genders
18+ years
Brief Summary
ACTION APAC is a cross-sectional, observational, descriptive, and exploratory survey-based study without collection of laboratory data. The study is not related to any specific treatment options or ph...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- People Living with Obesity
- Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
- Male or female, aged above or equal to 18 years at the time of signing informed consent
- Lives in one of the target countries
- Current BMI of at least 25 kg/m\^2 for all countries (except Singapore which has current BMI 27 kg/m\^2) based on self-reported height and weight
- Health Care Professionals
- Informed consent before any study related activities (study-related activities are any procedure related to recording/collection of data according to protocol)
- Male or female, aged greater than or equal to 18 years at the time of signing informed consent.
- Physician
- Primary Care Providers (PCPs) whose specialty is Family practice, General practice, Internal Medicine
- Non-PCP Specialties whose specialty is Endocrinologist, Cardiologist, Gastroenterologist, Obstetrics/Gynaecologist, Bariatrics/Obesity Medicine, Nutrition Specialist (physician) Orthopaedist, Aesthetics Medicine
- Specialty is not surgeon (including bariatric or plastic surgeon)
- Practices in the target countries
- In clinical practice for at least 2 years
- Spends at least 50% time in direct patient care
- Has seen at least 100 patients in past month
- Has seen at least 10 patients in past month who have obesity defined as: a patient with a BMI greater than or equal to 25 kg/m\^2 for all countries (except Singapore which has current greater than or equal to BMI 27 kg/m\^2) with or without comorbidities.
- Exclusion criteria:
- People Living with obesity
- Previous participation in this study. Participation is defined as having given online consent in this study
- Currently pregnant
- Participates in intense fitness or body building programs
- Has had significant, unintentional weight loss (due to major injury, illness, etc) in the past 6 months
- Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation
- Health Care Providers
- Previous participation in this study. Participation is defined as having given informed consent in this study.
- Unwillingness, inability, or language barriers precluding adequate understanding or cooperation
Exclusion
Key Trial Info
Start Date :
April 26 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 23 2022
Estimated Enrollment :
12404 Patients enrolled
Trial Details
Trial ID
NCT05250427
Start Date
April 26 2022
End Date
May 23 2022
Last Update
June 14 2022
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Novo Nordisk Investigational Site
Dhaka, Bangladesh
2
Novo Nordisk Investigational Site
Bangalore, India
3
Novo Nordisk Investigational Site
Jakarta, Indonesia
4
Novo Nordisk Investigational Site
Kuala Lumpur, Malaysia